TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
BUY
Solid operations and good growth prospects.
TOP PICK
Did a great deal with Hancock. Lots of capacity to buy from AIG. They will grow even further. Have a great Asian franchise.
TOP PICK
There is talk that they are looking at bits and pieces of AIG (AIG-N). This would be smart as there are some very profitable pieces internationally and in Canada. Have a depth of people throughout the company. Very reasonable multiple for a long-term holder.
BUY
Huge in the far east. First Canadian insurance company to get into China. Huge growth for them.
BUY
Likes its international diversification. The worry in the short term is the forthcoming change in CEO’s. Has a history of diversifying very well and growing outside of Canada and North America.
BUY
Great well run company. Missed the street on numbers but if you look at the components, they were actually quite good. A lot of great growth prospects in Asia.
HOLD
Canadian insurers sold off in light of the financial crisis but are still showing more solid characteristics than some of the US financials. Multiples have come down that it is now good value.
DON'T BUY
(Market Call Minute.) Great company. His concern is that when money starts moving back to the banks will it come out of the Lifecos.
DON'T BUY
Performance over the last little while has been less than stellar. Sees a flat line to slightly negative ahead. Doesn’t think market’s worries about insurance companies being the next place for financial problems is over. This company is pretty stable.
SELL
Banks have let go but the 2 major life insurance companies hung on. Sun Life has finally let go and this is the last of the companies that hasn't really set back to a level that he would be comfortable buying.
COMMENT
A superb company. Will continue to do well. Good marketing position in China and will be expanding that fairly rapidly. Good position in the US with John Hancock. Prefers Great West Lifeco (GWO-T) currently.
DON'T BUY
Sitting right on its support level and there is risk of it breaking down through it.
DON'T BUY
The whole of the financial sector is facing a big challenge going forward because of the subprime crisis in the US. Expect the company will do well over the next few years but can't see strong profit growth.
TOP PICK
When you can buy this under $40, it represents excellent value. One of the best managed and capitalized financial institutions in Canada. Sees them earning roughly $3 a share this year and about $3.30-$3.40 next year. ROE is the highest in the insurance group in between 16% and 18%.
BUY
They like it. This is a good entry point. Internationally they are tremendously successful. Made a brilliant acquisition in Hancock and executed it well. Change of CEO is a risk.
Showing 1,711 to 1,725 of 2,283 entries